ASP Isotopes Completes Well Drilling Required for Phase 1 of Renergen Helium Project Four Months Ahead of ScheduleDALLAS, March 23, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (
NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that the Company has completed the drilling of the wells required for Phase 1 of the Renergen Helium Project approximately four months ahead of schedule.
Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateRese-cel myositis BLA submission on track for 2027 based on a 17-patient, single arm registrational cohort design, including an outpatient dosing option
Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient ServicesMs. McDonough previously served as Senior Vice President of Patient Access, Analytics, and Operations at Krystal Biotech (Nasdaq: KRYS), where she helped lead the U.S. launch of VYJUVEK®, supporting its growth from FDA approval in 2023 to $389 million in annual sales in 2025
Bombardier Announces Successful Completion of Consent Solicitation with Respect to its 7.450% Notes due 2034MONTRÉAL, March 23, 2026 (GLOBE NEWSWIRE) -- Bombardier Inc. (“Bombardier”) today announced that, in connection with its previously announced consent solicitation with respect to its 7.450% Notes due 2034 (the “US Notes”), it has received the requisite written consents to amend the indenture governing the US Notes as reported by the U.S. Information and Tabulation Agent on the trade.
BridgeBio to Present Long-Term Efficacy and Safety Data from the ATTRibute-CM OLE Trial at the ACC Annual Scientific SessionsPALO ALTO, Calif., March 23, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, announced today that long-term efficacy and safety data in patients with ATTR-CM from the open-label extension (OLE) trial of ATTRibute-CM, its Phase 3 study of acoramidis, will be shared in a late-breaking oral presentation at the American College of Cardiology (ACC) Annual Scientific Sessions & Expo, taking place in New Orleans, Louisiana on March 28-30, 2026. Additionally, BridgeBio was selected to share three posters on additional OLE data and real-world survey findings.
Lexicon Pharmaceuticals and Novo Nordisk Announce initiation of Phase 1 study with oral obesity drug candidate LX9851LX9851 is a first-in-class, oral non-incretin candidate being developed by Novo Nordisk for the treatment of obesity and associated metabolic disorders
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate UpdateStrong financial position with cash, cash equivalents and marketable securities of $91.5M as of December 2025
Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan of ArrangementShareholders are Recommended to Vote “FOR” the Aptose BiosciencesProposed Plan of Arrangement with Hanmi Pharmaceutical
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial ResultsXTX501, a potential best-in-class bispecific PD-1 / masked IL-2, on track for planned IND submission in mid-2026 and Phase 1 initiation in the second half of 2026
FuelCell Energy Scales Up for Data Centers with Packaged 12.5 MW Utility‑Grade Power Block Solution and Manufacturing Expansion PlansDANBURY, Conn., March 23, 2026 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc. (
NASDAQ: FCEL) is taking significant steps toward meeting the speed of delivery and surging demand of data centers for on-site, utility‑scale continuous power.
JZXN to Deliver 100 Electric Heavy-Duty Trucks to Vietnam MarketHANGZHOU, China, March 23, 2026 (GLOBE NEWSWIRE) -- Jiuzi Holdings, Inc. (Nasdaq: JZXN, the “Company” or “Jiuzi”), today announced that the Company has recently completed a series of important business negotiations in Vietnam and has reached cooperation intentions with multiple local customers. The Company expects to deliver an initial batch of over 100 electric heavy-duty trucks to the Vietnam market. This milestone marks that Jiuzi’s strategic positioning in the Southeast Asian new energy commercial vehicle market has entered a substantive implementation phase.
Royalty Pharma Appoints Lucas Glass as Head of Artificial IntelligenceNEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Lucas Glass as Head of Artificial Intelligence, effective April 2026. Lucas will lead the development and implementation of artificial intelligence capabilities across Royalty Pharma.
OR Royalties Appoints Mr. Patrick Godin to Its Board of DirectorsMONTRÉAL, March 23, 2026 (GLOBE NEWSWIRE) -- OR Royalties Inc. (“OR Royalties” or the “Company”) (OR: TSX & NYSE) is pleased to announce the appointment of Mr. Patrick Godin as an Independent Director to its Board of Directors (the “Board”).
Go Rentals Elevates Private Aviation Experience with Leadership of Hiral Nelson and Kelsi YordiNEWPORT BEACH, Calif., March 23, 2026 (GLOBE NEWSWIRE) -- Go Rentals, the premier car rental company specializing in the private aviation market, announced the continued focus of its private aviation service model with the new leadership expertise of Hiral Nelson and Kelsi Yordi.
Ocugen to Host Webcast on Tuesday, March 24 at 8 a.m. EDT to Discuss Phase 2 Clinical Trial Data for OCU410—Modifier Gene Therapy for Geographic AtrophyMALVERN, Pa., March 23, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (
NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a conference call and live webcast with key opinion leaders (KOLs) and Ocugen executive leadership to discuss the full data set from the Phase 2 ArMaDa clinical trial evaluating OCU410 for geographic atrophy (GA), late-stage dry age-related macular degeneration (dAMD) at 8 a.m. EDT on Tuesday, March 24, 2026.
Profile Products Names Michael Ranchino Chief Executive OfficerRanchino to lead Profile’s next phase of growth, expanding leadership in specialty agriscience materials
PPHC Announces Acquisition of WPI StrategyEarnings accretive; expands UK advisory and economics capabilities
EAU Guidelines Upgrade Aquablation® Therapy to Strong Surgical Recommendation for BPHUpdated European Association of Urology guidelines reflect growing clinical evidence supporting Aquablation therapy in the surgical treatment of benign prostatic hyperplasia
USA Rare Earth and Arnold Magnetic Technologies Partner to Expand U.S.-Made Rare Earth Magnet Supply for Critical IndustriesSTILLWATER, Okla., March 23, 2026 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) ("USAR" or the "Company") today announced a mutual sales and distribution agreement with Arnold Magnetic Technologies Corp. (“Arnold”), a subsidiary of Compass Diversified (
NYSE: CODI), and a leading global manufacturer of high-performance magnets and precision components. The agreement strengthens the domestic supply chain for mission-critical applications by expanding availability of U.S.-manufactured rare earth magnets.
Plug Executive Leadership to Participate in Roth Annual Growth ConferenceSLINGERLANDS, N.Y., March 23, 2026 (GLOBE NEWSWIRE) -- Plug Power Inc. (
NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the hydrogen economy, today announced that members of its executive leadership team will participate in the Roth Annual Growth Conference in California. Plug representatives will engage with institutional investors to outline the Company’s priorities, market positioning, and financial outlook.
Trident Resources Announces Strategic Appointment of David Chan, P.Geo as Technical AdvisorVancouver, BC, March 23, 2026 (GLOBE NEWSWIRE) -- Trident Resources Corp. (TSX-V: ROCK) (OTCQB: TRDTF) (“Trident” or the “Company”) is pleased to announce the appointment of Mr. David T.M. Chan, B.Sc., P.Geo., as Technical Advisor, effective immediately.
Abaxx Exchange Reports Record Weekly Trading VolumeWeekly trading volume rose 343% last week to a record 54,740 contracts, with 7 active markets and record gold and LNG trading volumes
ST LNG Selects Baker Hughes as Technology Provider for U.S. Offshore LNG ProjectHOUSTON and LONDON, March 23, 2026 (GLOBE NEWSWIRE) -- Baker Hughes (
NASDAQ: BKR), an energy technology company, and ST LNG, LLC announced Monday an agreement under which Baker Hughes will supply critical gas compression, power generation equipment, and project development support for ST LNG’s proposed 8.4 million tonnes per annum (MTPA) liquefied natural gas (LNG) export terminal offshore of Matagorda, Texas.
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial ResultsCompleted target enrollment in Phase 1 monotherapy dose expansion study of micvotabart pelidotin (MICVO) in 2L+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) in the first quarter of 2026
Avalo Therapeutics Reports 2025 Financial Results and Recent Business UpdatesWAYNE, Pa., March 23, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) (“Avalo”), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today announced business updates and year-end financial results for 2025.
TransAlta Investor Day Highlights Solid Foundation and Attractive Growth to 2029 and BeyondCALGARY, Alberta, March 23, 2026 (GLOBE NEWSWIRE) -- TransAlta Corporation (TransAlta or the Company) (TSX: TA) (
NYSE: TAC) is pleased to host its 2026 Investor Day today, in Toronto and virtually. A subset of TransAlta's executive leadership team will discuss the Company’s outlook for the Alberta power market, along with its strategic priorities, financial position, and long-term path for rateable, attractive growth.
Ashland implements pricing actions across product portfolio in response to market volatilityWilmington, Del., March 23, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (
NYSE: ASH) is implementing pricing actions across its Life Sciences, Intermediates, Personal Care and Specialty Additives product portfolios globally in response to continued volatility in energy markets, raw material costs and logistics conditions stemming from the conflict in the Middle East.
Ingredion Announces Retirement of Gregory B. Kenny, Director, and Names Siobhán Talbot to Board of DirectorsWESTCHESTER, Ill., March 23, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (
NYSE: INGR), a leading global provider of ingredient solutions for food, beverage and industrial applications, today announced the retirement of long-serving board member Gregory B. Kenny, effective immediately, and the appointment of Siobhán Talbot to its board of directors, effective April 1.
The 24th China International Alcoholic Drinks Expo Kicks Off in Luzhou, China's "City of Liquor"LUZHOU, China, March 23, 2026 (GLOBE NEWSWIRE) -- From March 19 to 22, the 24th China International Alcoholic Drinks Expo was held at the Luzhou International Conference & Exhibition Center in Sichuan Province, China. Hosted by the China Alcoholic Drinks Association, this year's expo has invited Thailand to serve as the Guest Country of Honor.
EnviroGold Global Appoints Karina Nott as Chief Financial OfficerVANCOUVER, British Columbia, March 23, 2026 (GLOBE NEWSWIRE) -- EnviroGold Global Limited (TSX-V: NVRO | OTCQB: ESGLF | FSE: YGK) ("EnviroGold" or the "Company") is pleased to announce the appointment of Karina Nott as Chief Financial Officer. Ms. Nott joins EnviroGold as the Company advances the commercial deployment of its proprietary NVRO Process™ and toward achieving key commercialization milestones and revenue targets.
Apogee Therapeutics Announces Positive Phase 2 Part A 52-Week Data of Zumilokibart (APG777), Demonstrating Maintenance and Deepening of Responses with Every 3- and 6-Month Dosing in Moderate-to-Severe Atopic DermatitisAPEX Part A data demonstrated durable maintenance of response at 52-weeks for every 3- and 6-months dosing, respectively, including:- 75% and 85% patients maintained EASI-75- 86% and 78% patients maintained vIGA 0/1Deepening of response was observed across all lesional and itch endpoints with both every 3- and 6- month dosing among the full population of patients initially randomized to zumilokibart
Bunker Hill Announces Graduation to the Toronto Stock Exchange and on Track for Restart of Operations in June 2026KELLOGG, Idaho and VANCOUVER, British Columbia, March 23, 2026 (GLOBE NEWSWIRE) -- Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX-V: BNKR | OTCQB: BHLL) announced today that it has received approval for listing of the Company’s shares of common stock (the “Common Shares”) on the Toronto Stock Exchange (the “TSX”) and remains on track for the restart of operations in June 2026.
KBR Announces Strategic Investment in Applied Computing to Accelerate AI Driven Innovation Across Energy and Industrial MarketsHOUSTON, March 23, 2026 (GLOBE NEWSWIRE) -- KBR (
NYSE: KBR) today announced a strategic investment in UK-based Applied Computing, marking a significant step forward in KBR’s AI driven growth strategy. As part of the investment, KBR has also secured a board position in the company.
U.S. Census Bureau: Hispanics Reach 10.2 Million HomeownersA New NAHREP report shows that Hispanics dominated homeownership and new household formation growth in 2025
PyroGenesis Schedules 2025 Fiscal Year Financial Results and Business Update Conference CallMONTREAL, March 23, 2026 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis” or “the Company”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to heavy industry & defense, announces today that it will host a conference call at 12:00 PM Eastern Time on Tuesday, March 31, 2026 to discuss the Company’s financial results for the fourth quarter and fiscal year 2025, which ended December, 31, 2025, as well as provide an update to the Company’s progress and other developments.
General (Ret.) Christopher Cavoli, Former EUCOM Commander and Supreme Allied Commander Europe, Joins Pallas Speakers BureauWASHINGTON, March 23, 2026 (GLOBE NEWSWIRE) -- Pallas Advisors is pleased to announce that General (Ret.) Christopher Cavoli has joined the Pallas Speakers Bureau, a platform connecting global audiences with top-tier national security experts. Since retiring in 2025, General Cavoli has joined Valor Equity Partners as a Partner.
McEwen Reports Tartan Mine Project Gold Mineral Resource Estimate308,900 oz Indicated and 302,700 oz InferredRecent Drilling Points to Potential ExpansionDevelopment Plans Update
T1 Energy Announces Fourth Quarter and Full-Year 2025 Earnings Release and Conference Call ScheduleAUSTIN, Texas and NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- T1 Energy Inc. (
NYSE: TE) (“T1,” “T1 Energy,” or the “Company”) announced this morning that the Company will publish a press release detailing fourth quarter and full-year 2025 results and conduct a conference call on March 31, 2026.
Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive OfficerBASEL, Switzerland, March 23, 2026 (GLOBE NEWSWIRE) -- Anaveon, a late-stage preclinical biotech focused on reprogramming the immune system with precision biologics, announces today the appointment of Thaminda Ramanayake as its new Chief Executive Officer.
ONWARD Medical Schedules Webcast to Report Full-Year 2025 Financial Results and Provide Business UpdateEINDHOVEN, the Netherlands, March 23, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury and other movement disabilities, today announces that it will report Full-Year 2025 Financial Results and host a webcast to provide a comprehensive business update on March 31, 2026.
STMicroelectronics China-manufactured STM32 microcontrollers begin volume productionSTMicroelectronics China-manufactured STM32 microcontrollers begin volume production
CoaguSense Announces Agreement to Acquire DOASENSE DOAC Testing Business, Expanding Leadership in Anticoagulation MonitoringFREMONT, Calif., March 22, 2026 (GLOBE NEWSWIRE) -- CoaguSense, Inc., a leading developer of point-of-care coagulation monitoring systems and a subsidiary of i-SENS, Inc. (KOSDAQ: 099190), today announced it has entered into a definitive asset purchase agreement to acquire the business of DOASENSE GmbH, Heidelberg, a pioneer in specialized diagnostic solutions for Direct Oral Anticoagulants (DOACs).
NetAlly Launches New LinkRunner Network and Cable TesterThe LinkRunner® AT 1500 provides fast copper network link and cable testing for frontline network technicians, including PoE++ validation up to 90W
Olympians Inspire Expands School Assembly and Leadership Workshop Programming Featuring Elite AthletesNorth Las Vegas, NV, March 22, 2026 (GLOBE NEWSWIRE) -- Olympians Inspire, an education-focused youth development organization based in North Las Vegas, Nevada, announced the expansion of its school-based programming designed to connect students with elite athletes through assemblies, workshops, and mentorship events. The initiative will bring elite competitors and other high-level athletes into schools across the United States to speak with students about perseverance, discipline, and leadership.
HUTCHMED Initiates Phase III Trial of HMPL-760 in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma in ChinaHONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 23, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated a registrational Phase III clinical trial of HMPL-760 in combination with R-GemOx (rituximab, gemcitabine and oxaliplatin) in patients with relapsed/refractory diffuse large B-cell lymphoma (“DLBCL”) in China. The first patient received the first dose on March 20, 2026.
THE CHAMPIONS COLLECTIVE PRESENTS GOTHAM FC’S 2025 NWSL CHAMPIONSHIP RING HONORING SECOND TITLEHarrison, NJ, March 21, 2026 (GLOBE NEWSWIRE) -- In partnership with The Champions Collective, Gotham FC celebrated the delivery of their 2025 NWSL Championship ring during a public ceremony at Sports Illustrated Stadium following their home opener.
HII Celebrates 2025 Graduates of The Newport News Shipbuilding Apprentice SchoolNEWPORT NEWS, Va., March 21, 2026 (GLOBE NEWSWIRE) -- HII (
NYSE: HII) hosted commencement exercises today, celebrating 128 graduates of the company’s Newport News Shipbuilding Apprentice School. The ceremony was held at Liberty Live Church in Hampton.
TRUBRIDGE ALERT: Bragar Eagel & Squire, P.C. is Investigating TruBridge, Inc. on Behalf of TruBridge Stockholders and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In TruBridge (TBRG)To Contact Him Directly To Discuss Their Options
ARQ INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Arq, Inc. on Behalf of Arq Stockholders and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Arq To Contact Him Directly To Discuss Their Options
Boat Lift and Dock Costs in 2026: A Market OverviewBuffalo, NY, March 20, 2026 (GLOBE NEWSWIRE) -- Boat lift and dock system costs in 2026 continue to vary widely based on size, materials, and site conditions. This overview reflects general industry pricing trends based on common residential project ranges and manufacturer-published data, with input from RGC Marine, a division of RGC Products. It outlines typical price ranges for equipment, installation costs, and the key factors that influence overall project pricing for residential waterfront properties.
